Related Experiment Video

Updated: Jul 4, 2026

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
05:20

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion

Published on: November 12, 2020

Management of acute central retinal artery occlusion

Celia S Chen1, Andrew W Lee

  • 1Department of Ophthalmology, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.

Nature Clinical Practice. Neurology
|June 11, 2008
PubMed

Insights

Central retinal artery occlusion (CRAO) causes severe vision loss and has poor recovery. Thrombolytic therapy shows promise for acute CRAO management, but further randomized trials are needed for clinical recommendation.

Area of Science:

  • Ophthalmology
  • Neurology
  • Vascular Medicine

Background:

  • Central retinal artery occlusion (CRAO) is an ocular stroke leading to significant vision impairment.
  • The primary cause of CRAO is thromboembolism within the central retinal artery.
  • Current treatments for CRAO have limited success in altering the disease's prognosis.

Purpose of the Study:

  • To evaluate the potential of thrombolytic therapy in improving visual outcomes for acute CRAO.
  • To assess the need for randomized controlled trials to validate thrombolytic therapy's efficacy.

Main Methods:

  • Review of nonrandomized studies on thrombolytic therapy for CRAO.
  • Analysis of visual outcome data from existing literature.
  • Identification of the necessity for randomized controlled trials (RCTs).

Main Results:

  • Nonrandomized studies suggest thrombolytic therapy may improve visual outcomes in acute CRAO.
  • Standard therapies have not demonstrated efficacy in changing the disease course.
  • Evidence from nonrandomized studies indicates potential benefits of thrombolysis.

Conclusions:

  • Thrombolytic therapy presents a promising treatment option for acute central retinal artery occlusion.
  • Randomized controlled trials are essential to confirm the efficacy and safety of thrombolytic therapy for CRAO before widespread clinical adoption.
  • Further research is required to establish thrombolysis as a standard treatment for CRAO.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...